Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Entrada Therapeutics (TRDA) Q2 2025 Earnings
TRDA
8
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.79
-0.01
0.77
1.55
Details
Expected EPS
-0.7886
Actual EPS
-0.42
Surprise EPS
0.37
Surprise Percent
+46.74%
Description
Entrada Therapeutics (TRDA) has reported earnings of -0.42 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login